Samsung Bioepis Scoops First EU Lucentis Biosimilar As 2022 Date Looms

Byooviz Biosimilar Backed By EMA Committee In June

 
• By Dean Rudge
  
Eye
Byooviz is to be marketed in Europe by Biogen • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products